Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Alvar

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
The Journal of Antimicrobial Chemotherapy|July 31, 2003
Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot studyFernando Laguna, Sebastián Videla, Manuel E Jiménez-Mejías, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2018
Quantifying the Infectiousness of Post-Kala-Azar Dermal Leishmaniasis Toward Sand FliesDinesh Mondal, Caryn Bern, Debashis Ghosh, et al.
Plos Neglected Tropical Diseases|November 9, 2018
Barriers to access to visceral leishmaniasis diagnosis and care among seasonal mobile workers in Western Tigray, Northern Ethiopia: A qualitative studyRebecca Marie Coulborn, Tesfay Gebregzabher Gebrehiwot, Martin Schneider, et al.
Microorganisms|July 2, 2021
In Vitro Susceptibility to Miltefosine of <i>Leishmania infantum</i> (syn. <i>L.</i> <i>chagasi</i>) Isolates from Different Geographical Areas in BrazilCaroline Ricce Espada, Erica V de Castro Levatti, Mariana Côrtes Boité, et al.
Plos Neglected Tropical Diseases|July 21, 2020
Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, IndiaVishal Goyal, Vidya Nand Rabi Das, Shambhu Nath Singh, et al.
The Journal of Antimicrobial Chemotherapy|January 24, 2004
Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patientsRogelio López-Vélez, Sebastián Videla, Manuel Márquez, et al.
Vaccine|March 7, 2008
Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasisEugenia Carrillo, Martín Crusat, Javier Nieto, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2020
Inferring transmission trees to guide targeting of interventions against visceral leishmaniasis and post-kala-azar dermal leishmaniasisLloyd A C Chapman, Simon E F Spencer, Timothy M Pollington, et al.
Plos Neglected Tropical Diseases|September 17, 2019
Effect of insecticide-treated bed nets on visceral leishmaniasis incidence in Bangladesh. A retrospective cohort analysisRajib Chowdhury, Vashkar Chowdhury, Shyla Faria, et al.
Plos Neglected Tropical Diseases|March 8, 2014
Epidemiology of visceral leishmaniasis in GeorgiaGiorgi Babuadze, Jorge Alvar, Daniel Argaw, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
The Journal of Antimicrobial Chemotherapy|July 31, 2003
Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot studyFernando Laguna, Sebastián Videla, Manuel E Jiménez-Mejías, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2018
Quantifying the Infectiousness of Post-Kala-Azar Dermal Leishmaniasis Toward Sand FliesDinesh Mondal, Caryn Bern, Debashis Ghosh, et al.
Plos Neglected Tropical Diseases|November 9, 2018
Barriers to access to visceral leishmaniasis diagnosis and care among seasonal mobile workers in Western Tigray, Northern Ethiopia: A qualitative studyRebecca Marie Coulborn, Tesfay Gebregzabher Gebrehiwot, Martin Schneider, et al.
Microorganisms|July 2, 2021
In Vitro Susceptibility to Miltefosine of <i>Leishmania infantum</i> (syn. <i>L.</i> <i>chagasi</i>) Isolates from Different Geographical Areas in BrazilCaroline Ricce Espada, Erica V de Castro Levatti, Mariana Côrtes Boité, et al.
Plos Neglected Tropical Diseases|July 21, 2020
Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, IndiaVishal Goyal, Vidya Nand Rabi Das, Shambhu Nath Singh, et al.
The Journal of Antimicrobial Chemotherapy|January 24, 2004
Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patientsRogelio López-Vélez, Sebastián Videla, Manuel Márquez, et al.
Vaccine|March 7, 2008
Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasisEugenia Carrillo, Martín Crusat, Javier Nieto, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2020
Inferring transmission trees to guide targeting of interventions against visceral leishmaniasis and post-kala-azar dermal leishmaniasisLloyd A C Chapman, Simon E F Spencer, Timothy M Pollington, et al.
Plos Neglected Tropical Diseases|September 17, 2019
Effect of insecticide-treated bed nets on visceral leishmaniasis incidence in Bangladesh. A retrospective cohort analysisRajib Chowdhury, Vashkar Chowdhury, Shyla Faria, et al.
Plos Neglected Tropical Diseases|March 8, 2014
Epidemiology of visceral leishmaniasis in GeorgiaGiorgi Babuadze, Jorge Alvar, Daniel Argaw, et al.
Pageof 10